Fertram Sigurjonsson, Founder and CEO of Medical-Fish-Skin Company Kerecis, Receives the EWMA President’s Wound Care Entrepreneur of the Year Award
May 03 2024 - 11:56AM
Business Wire
The European Wound Management Association (EWMA) presented
Fertram Sigurjonsson, founder and CEO of the medical-fish-skin
company Kerecis, with the President’s Wound Care Entrepreneur of
the Year Award. The award was announced at the annual EWMA
Innovation Forum.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240503572390/en/
Fertram Sigurjonsson, Founder and CEO of
Kerecis, receives the President’s Wound Care Entrepreneur of the
Year Award from Kirsi Isoherranen, President of European Wound Care
Association (EWMA). (Photo: Business Wire)
This award celebrates individuals who have “demonstrated
exceptional entrepreneurial spirit, making significant strides in
advancing wound care solutions and improving patient lives.” In its
announcement, the EWMA stated that Sigurjonsson “exemplifies the
essence of entrepreneurship with his groundbreaking work in tissue
regeneration.”
Under Sigurjonsson's leadership, Kerecis has developed products
from fish skin and fatty acids for cellular therapy, tissue
regeneration and protection. The products are primarily used to
treat chronic and acute wounds, burns, surgical wounds and trauma.
When grafted onto damaged human tissue or implanted, the patented
material supports the body’s own processes to heal and regenerate.
Clinical studies have found that the Kerecis products heal wounds
faster than competing products and are cost effective. To date,
tens of thousands of patients have benefitted from being treated
with Kerecis fish skin.
“Receiving this award is a milestone in our journey—from idea to
life-changing impact. It's truly gratifying for me to see my
invention succeed and significantly improve health outcomes.
Kerecis remains dedicated to the entrepreneurial spirit, always
listening to and learning from doctors and patients. We will
continue pushing science's boundaries to meet their needs and
advance medical treatment,” said Sigurjonsson.
About Kerecis
Kerecis develops products from fish skin and fatty acids for
cellular therapy, tissue regeneration and protection. When grafted
onto damaged human tissue or implanted, the patented material
supports the body’s own processes to heal and regenerate. Because
no disease-transfer risk exists between cold-water fish and humans,
the Kerecis fish skin is only gently processed and retains its
similarity to human tissue. The gentle processing preserves the
skin’s original three-dimensional structure, maintaining its
inherent natural strength, complexity and molecules (such as fatty
acids). Clinical studies have found that the Kerecis products heal
wounds faster than competing products and are found cost effective.
Kerecis is the only approved manufacturer of medical devices
containing intact fish skin globally.
Kerecis is the fastest-growing and one of the top five companies
in the U.S. biologics-skin and dermal-substitute market, according
to SmartTRAK Business Intelligence. Kerecis’ expanding product
portfolio includes SurgiBind®/SurgiClose®, which are used for
reconstructive surgery in hospital operating rooms; GraftGuide®,
which is mostly sold to burn centers; and MariGen® and Shield™,
which are sold to healthcare facilities to treat chronic wounds
such as diabetic wounds, as well as post-Moh's surgery wounds.
Kerecis is committed to the United Nations Sustainable
Development Goals. The fish skin used in Kerecis’ products derives
from wild and sustainable fish stock caught in pristine Icelandic
waters and processed with 100% renewable energy in the town of
Isafjordur, close to the Arctic Circle. Kerecis is part of
Coloplast, the leading global supplier of intimate healthcare
products. For more information, visit https://www.kerecis.com.
Trademarks and registered trademarks are the property of their
respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240503572390/en/
Kay Paumier Communications Plus kay@communicationsplus.net
408-370-1243 (office) 408-806-1177 (mobile)